Browsing by Author "Zúñiga Avendaño, Álvaro Alfonso"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Cáncer de recto. Análisis de las complicaciones post operatorias y mortalidad de la resección radical en una serie de 10 años
    (2013) Gellona V., José; Bellolio R., Felipe; Molina Pezoa, María Elena; Miguieles Cocco, Rodrigo Alfonso; Urrejola Schmied, Gonzalo Ignacio; Zúñiga Avendaño, Álvaro Alfonso
  • No Thumbnail Available
    Item
    Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer
    (2021) Cárcamo Gruebler, Leonardo; Peñailillo Toledo, Eduardo; Bellolio R., Felipe; Miguieles Cocco, Rodrigo Alfonso; Urrejola Schmied, Gonzalo Ignacio; Zúñiga Avendaño, Álvaro Alfonso; Molina Pezoa, María Elena; Larach Kattan, José Tomás
  • Thumbnail Image
    Item
    Protective role of intravesical BCG in COVID-19 severity
    (2021) Gallegos, Héctor; Rojas, Pablo A.; Sepúlveda, Francisca; Zúñiga Avendaño, Álvaro Alfonso; San Francisco Reyes, Ignacio Felipe
    Abstract Objectives To establish the role of BCG instillations in the incidence and mortality of COVID-19. Patients and methods NMIBC patients in instillations with BCG (induction or maintenance) during 2019/2020 were included, establishing a COVID-19 group (with a diagnosis according to the national registry) and a control group (NO-COVID). The cumulative incidence (cases/total patients) and the case fatality rate (deaths/cases) were established, and compared with the national statistics for the same age group. T-test was used for continuous variables and Fisher's exact test for categorical variables. Results 175 patients were included. Eleven patients presented CIS (11/175, 6.3%), 84/175 (48.0%) Ta and 68/175 (38.9%) T1. Average number of instillations = 13.25 ± 7.4. One hundred sixty-seven patients (95.4%) had complete induction. Forty-three patients (cumulative incidence 24.6%) were diagnosed with COVID-19. There is no difference between COVID-19 and NO-COVID group in age, gender or proportion of maintenance completed. COVID-19 group fatality rate = 1/43 (2.3%). Accumulated Chilean incidence 70–79 years = 6.3%. Chilean fatality rate 70–79 years = 14%. Conclusions According to our results, patients with NMIBC submitted to instillations with BCG have a lower case-fatality rate than the national registry of patients between 70 and 79 years (2.3% vs. 14%, respectively). Intravesical BCG could decrease the mortality due to COVID-19, so instillation schemes should not be suspended in a pandemic.